I thought I had an allergy to alcohol when I saw my cheeks flush bright red after a drink, but it turns out there's a unique ...

Zantac and ranitidine are routinely used by millions of heartburn sufferers. ... The agency tested samples of over-the-counter alternatives such as Pepcid, Tagamet, ...

Safe alternatives to Zantac are available. The drug is one of several H2-receptor antagonists (H2RAs), including cimetidine (Tagamet) and famotidine (Pepcid).Testing does not show that these drugs ...

If you’ve been prescribed famotidine and you’re interested in taking Pepcid AC or Zantac 360 instead, talk with your doctor. They may prefer that you take one version instead of the other.

In the United States alone, about 1 in 10 adults use these drugs regularly. Some well-known brands include Prilosec, Nexium, ...

Sanofi has since returned Zantac to store shelves but without ranitidine. It is now made with famotidine, the active ingredient in competitor Pepcid. Originally Published: May 8, 2024 at 12:53 PM CDT ...

It’s now made with famotidine, the active ingredient in competitor Pepcid. Zantac is still one of the US’s leading heartburn treatments in a market that generated $14 billion in sales last year.

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of ...

Sanofi has since returned Zantac to store shelves, but without ranitidine. It’s now made with famotidine, the active ingredient in competitor Pepcid. Zantac is the third leading antacid sold in ...

After the FDA recall, Sanofi won approval to return Zantac to US store shelves, but without ranitidine. It’s now made with famotidine, the active ingredient in competitor Pepcid, which is ...

Sanofi reintroduced Zantac without ranitidine and is now using famotidine. Market-moving news hits Benzinga Pro first—get a 30-minute edge and save 60% this 4th of July.

Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.